Seronegative Spondyloarthropathies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2013-03-22
Clinical Trial Update: Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain [Phase 3]
A Phase 3 randomized trial comparing combination disease-modifying antirheumatic drugs (DMARDs) versus sulfasalazine for inflammatory back p…